Study on bringing AMR medical countermeasures to the market
This report focuses upon the prospective roles and responsibilities of the European Union (EU); specifically in supporting new developments in the pipeline and ensuring access to Antimicrobial Resistance (AMR) Medical Countermeasures (MCMs) brought to market. Survey respondents: - expect DG HERA to play an important role in the implementation of a new pull mechanism; - expect DG HERA to contribute or complement existing financial push incentives; and - noted that DG HERA could assist with the provision of non-financial support, including knowledge sharing, dissemination of best practices and capacity building for Member States.
|